SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $132,000 | +36.1% | 136,939 | +66.3% | 0.00% | – |
| Q1 2022 | $97,000 | -95.0% | 82,354 | -76.8% | 0.00% | -100.0% |
| Q2 2021 | $1,932,000 | +1433.3% | 354,453 | +2942.0% | 0.01% | – |
| Q4 2020 | $126,000 | +207.3% | 11,652 | +148.7% | 0.00% | – |
| Q3 2020 | $41,000 | -93.1% | 4,686 | -91.6% | 0.00% | -100.0% |
| Q2 2020 | $598,000 | +228.6% | 56,026 | +112.2% | 0.00% | +200.0% |
| Q4 2019 | $182,000 | +83.8% | 26,405 | +144.8% | 0.00% | – |
| Q1 2019 | $99,000 | +50.0% | 10,788 | +95.0% | 0.00% | – |
| Q3 2018 | $66,000 | -77.1% | 5,531 | -80.4% | 0.00% | -100.0% |
| Q2 2018 | $288,000 | +5660.0% | 28,233 | +7084.0% | 0.00% | – |
| Q1 2018 | $5,000 | – | 393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |